Clinical Manifestations and Management of Terbinafine-Induced Acute Generalized Exanthematous Pustulosis

Table 3

Treatment and prognosis of 32 patients with terbinafine-induced acute generalized exanthematous pustulosis.

Parameters		Values
Treatment	Discontinued	32 (100%)
	Topical steroids	11 (34.4%)
	Systemic steroids	15 (46.9%)
	Antihistamines	5 (15.6%)
	Systemic supportive care	10 (31.3%)
Outcome	Recovery	32 (100%)
Recovery time (26)^a	Days	12 (2, 90)^b
Naranjo probability scale	Probable	32 (100%)
EuroSCAR^#	Probable	6 (18.8%)
	Definite	26 (81.3%)

NA, not available and EuroSCAR, European Study of Severe Cutaneous Adverse Reactions. ^arepresents the number of patients out of 32 on which information regarding this particular parameter was provided. ^bMedian (minimum-maximum). Score interpretation: doubtful (0), possible (1–4), probable (5–8), and definite (≥9). ^#Score interpretation: no (≤0), possible (1–4), probable (5–7), and definite (8–12).